| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 6,458,437 | 4,560,549 |
| Net decrease in cash and cash equivalents | -3,577,663 | -2,235,610 |
| Cash and cash equivalents at beginning of period | 4,674,572 | - |
| Cash and cash equivalents at end of period | 1,096,909 | - |
HCW Biologics Inc. (HCWB)
HCW Biologics Inc. (HCWB)